Mr. Jeremy Masding:

In our restructuring package agreed with the European Commission, we have an obligation to manage that cohort of loans by the end of 2018. I think it goes back to the original question asked at the start of this session. Again, as I said on the record, we do not want to get into a position whereby we are selling those loans, so our aspiration is to continue to work hard to try to court customers into treatments, or as many of those as we possibly can.